Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1001/jamainternmed.2020.2904 http://scihub22266oqcxt.onion/10.1001/jamainternmed.2020.2904 32730617!7385669!32730617     free     free     free Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 211.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       JAMA+Intern+Med 2020 ; 180 (10): 1398-1400 Nephropedia Template TP {{tp|p=32730617|t=2020. Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials gov |pdf=|usr=}}{{32730617}} gab.com Text Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials gov JO: JAMA Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32730617 #FOAvip This cross-sectional study evaluates the characteristics and expected strength of evidence of coronavirus disease 2019 studies registered on ClinicalTrials.gov. Twit Text FOAVip Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials gov ????JAMA Intern Med http://www.kidney.de/pget.php?&tw=1&pmid=32730617 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32730617 #FOAvip English Wikipedia <ref>{{Cite pmid|32730617}}</ref> Characteristics and Strength of Evidence of COVID-19 Studies Registered on ClinicalTrials gov #MMPMID32730617 Pundi K; Perino AC; Harrington RA; Krumholz HM; Turakhia MP JAMA Intern Med 2020[Oct]; 180 (10): 1398-1400 PMID32730617show ga This cross-sectional study evaluates the characteristics and expected strength of evidence of coronavirus disease 2019 studies registered on ClinicalTrials.gov. |*Coronavirus Infections/epidemiology/prevention & control/therapy[MESH] |*Evidence-Based Medicine/methods/standards[MESH] |*Outcome Assessment, Health Care/methods/standards[MESH] |*Pandemics/prevention & control[MESH] |*Pneumonia, Viral/epidemiology/prevention & control/therapy[MESH] |*Research Design/standards/statistics & numerical data[MESH] |Betacoronavirus[MESH] |COVID-19[MESH] |Clinical Trials as Topic[MESH] |Cross-Sectional Studies[MESH] |Data Accuracy[MESH] |Humans[MESH] |Needs Assessment[MESH] |Registries[MESH]Characteristics and Strength of Evidence of COVID-19 Studies Registere(epmc).pdf DeepDyve Pubget Overpricing